3rd Global Summit on Brain Disorders and Therapeutics

February 15-16, 2023 | Switzerland

3rd Global Summit
On behalf of the 3rd Global Summit on Brain Disorders and Therapeutics, we are delighted to welcome you to join the Conference scheduled on February 15-16, 2023 Zurich, Switzerland.

Spotlight

Welcome to Pharmaprojects’ 2023 review of trends in pharmaceutical R&D. For over 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’llexamine the state of play at the start of 2023.


OTHER PAST CONFERENCES

2023 QC Micro Summit

March 21-23, 2023 | USA

Get ready for three days of presentations covering the most important topics affecting pharmaceutical quality control and microbiology, with opportunities to ask questions and network with industry leaders and like-minded peers.

International Conference on Clinical Ethics Consultation

April 4-5, 2023 | Netherlands

Welcome to International Conference on Clinical Ethics Consultation (ICCEC - 23), an exciting event that strives to bring together all stakeholders in the discipline of Clinical Ethics Consultation to promote authentic and accelerated scientific research progress

International Conference on Pharmaceutical Analysis, Drug Discovery and Designing Chemistry (PADDDC-23)

April 6, 2023 | Italy

International Conference on Pharmaceutical Analysis, Drug Discovery and Designing Chemistry (PADDDC-23) at Rome, Italy strives to serve all those engaged in the discipline of Pharmaceutical Analysis, Drug Discovery and Designing Chemistry as an avenue for growth and community-building.

Medicinal & Pharmaceutical Sciences

March 28, 2023 | Spain

The upcoming (ICMPS-23) at Madrid, Spain has been organized on 28th-Mar-2023 and scheduled to alleviate this exact challenge by serving as a focal point for reseachers in the discipline of Medicinal & Pharmaceutical Sciences

Spotlight

Welcome to Pharmaprojects’ 2023 review of trends in pharmaceutical R&D. For over 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’llexamine the state of play at the start of 2023.

resources